Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 31 P233 | DOI: 10.1530/endoabs.31.P233

SFEBES2013 Poster Presentations Obesity, diabetes, metabolism and cardiovascular (67 abstracts)

Pregnancy outcome in a patient with lipodystrophy and type 2 diabetes

Tolulope Shonibare & Muhammad Butt

Huddersfield Royal Infirmary, Huddersfield, UK.

Background: A 23-year-old woman diagnosed with Dunnigan-type familial partial lipodystrophy (FPLD) attended the joint Antenatal/Endocrine Clinic at 13 weeks of gestation. She was diagnosed at age 7 and subsequently developed type 2 diabetes at age 11 years. She was managed initially with metformin followed by addition of insulin. It was an unplanned pregnancy and her booking HbA1c was 8.4% (IFCC 68 mmol/mol).

Prior to pregnancy, she was on a basal bolus regime of Levemir and Novorapid and her total daily insulin dose was ~180 units. At booking, we added Metformin 500 mg twice daily, which was later increased to three times daily.

Her insulin requirements escalated rapidly to a total daily dose of 250 units by 25 weeks gestation. At this stage, the use of Humulin R (U500) was considered and discussed with the patient. However, she presented with vaginal spotting and went into spontaneous labour at 26 weeks. She delivered a live female infant who was admitted briefly to the special care baby unit. During labour she was managed with intravenous sliding scale insulin.

Conclusion: Familial Lipodystrophy is a group of rare disorders associated with numerous metabolic complications. Diabetes, familial lipodystrophy and pregnancy in combination all compound and confer a severe insulin resistant state which if poorly controlled, can have an adverse effect on pregnancy outcome. Data on the use of U500 insulin during pregnancy is limited however there are a handful of case reports of its use in pregnancy with successful management of glycaemic and obstetric outcome.

This case is a reminder of the challenges in the glycaemic management of patients with lipodystrophy particularly in pregnancy. It also adds to the limited literature available on pregnancy outcome of patients with lipodystrophy.

Article tools

My recent searches

No recent searches.